Priya cmi (3) - PowerPoint PPT Presentation

About This Presentation
Title:

Priya cmi (3)

Description:

: Read here the market research report published by CMI team – PowerPoint PPT presentation

Number of Views:12
Slides: 13
Provided by: PRIYACMI
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Priya cmi (3)


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
LIOTHYRONINE MARKET ANALYSIS
  • Liothyronine Market, by Product Type
    (Liothyronine Sodium, Combination Therapies,
    Others), by Indication (Hypothyroidism, Goiter,
    and Myxedema), by Distribution Channel (Hospital
    Pharmacies, Retail Pharmacies, Speciality Clinics
    and Online Pharmacies), and by Region (North
    America, Latin America, Europe, Middle East, Asia
    Pacific, and Africa) - Size, Share, Outlook, and
    Opportunity Analysis, 2020 - 2027

3
  • Liothyronine is synthetically manufactured form
    of thyroid hormone, triiodothyronine (T3), which
    is produced by thyroid gland to boost energy and
    metabolism in human body. Liothyronine is used in
    the treatment of hypothyroidism and in surgical
    treatment of people with thyroid cancer.
    Liothyronine is administered orally in patients
    after having meal as directed by physician. Apart
    from thyroid related conditions, liothyronine is
    used in treatment of Myxedema.
  • Global Liothyronine Market Drivers
  • Increasing prevalence of thyroid related
    conditions owing to factors such as unhealthy
    diet, and modified life style has increased in
    the thyroid conditions such as hypothyroidism.
    For instance, according to the National Institute
    of Health 2019 report, hypothyroidism affects
    around 5 of individuals worldwide each year.
    Therefore, pharmaceutical companies are focusing
    on advancement in the field of treatment of
    thyroid related conditions, which is expected to
    drive growth of global liothyronine market. For
    instance, in 2019, Titan Pharmaceuticals, Inc.
    presented the clinical data on efficiency of
    'ProNeura', a sub-dermal implant, characterized
    with properties such as sustain release dosage
    form in treatment of hypothyroidism. These
    factors are expected to drive the global
    liothyronine market over the forecast period.

4
  • Market Restraints
  • Liothyronine drug is associated with side effects
    such as temporary hair loss in initial days of
    treatment, which is mainly observed in children.
    Moreover, liothyronine is associated with some
    common side effects such as nervousness,
    increased sweating, and diarrhoea. Furthermore,
    liothyronine is contraindicated in patients with
    obesity and patients with weight issues. These
    factors are expected to restrain the global
    liothyronine market.

5
  • Market Regional Analysis
  • On the basis of region, global liothyronine
    market is segmented into North America, Latin
    America, Europe, Asia Pacific, Middle East, and
    Africa. In North America, hypothyroidism is
    having high prevalence in the U.S. because of
    decreased thyroid hormone production in
    individuals, owing to changes in lifestyle and
    unhealthy diet. For instance, according to the
    American Thyroid Association report 2019, 12 of
    the U.S. population suffered from thyroid and 60
    of the population were unaware of thyroid related
    conditions. Therefore, pharmaceutical companies
    are focusing on product approvals for treatment
    of hypothyroidism to strengthen their market
    share. For instance, in 2017, ITL Pharma, Inc.
    (ITL), a pharmaceutical research company,
    received approval for its Trithyroid
    (liothyronine, T3), as a sustain drug release
    under the category of patent protection by the
    U.S. Food Drug and Administration.
  • In Europe, according to the National Institute of
    Health 2019 report, prevalence of hypothyroidism
    was 4.49 in the region. Therefore,
    pharmaceutical companies are focusing on product
    launches for treatment of hypothyroidism to
    strengthen their market share. For instance, in
    2019, Bioiberica S.A.U, a manufacturer of natural
    active pharmaceutical ingredients, launched
    thyroxime and liothyronine from human thyroid
    glands indicated for the treatment of
    hypothyroidism.

6
  • Global Liothyronine Market COVID-19 Impact
    Analysis
  • Since the outbreak of COVID-19 pandemic, every
    sector and industry around the globe is
    negatively affected. In case of the global
    liothyronine market, patients suffering from
    thyroid related conditions have to undergo
    regular thyroid function test to check the
    thyroid organ functionality and modify dosage
    according to the results. However, lockdowns by
    governments of various countries have resulted in
    difficulty in regular tests and appointments for
    patients. Moreover, the governments of various
    countries such as India, the U.S., Italy, and
    others have imposed ban on non-urgent surgical
    treatments due to COVID-19. Thus, patients who
    have been suggested thyroid surgery would have to
    wait till the ban lifts.

7
  • Global Liothyronine Market Key Players
  • Key operating players in global liothyronine
    market include LGM Pharma, LLC, HBCChem, Inc.,
    EMMX Biotechnology LLC, Toronto Research
    Chemicals, 3B Scientific, Apollo Scientific Ltd,
    American Biochemicals Inc, Acros Organics
    B.V.B.A, Suzhou Ryan Pharmaceutical Technology
    Co, ITL Pharma, Inc, Bioiberica S.A.U, and Titan
    Pharmaceuticals, Inc.
  • Market Taxonomy
  • On the basis of product type, the global
    liothyronine market is segmented into
  • Liothyronine Sodium
  • Combination Therapies
  • Others

8
  • On the basis of distribution channel, the global
    liothyronine market is segmented into
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • On the basis of indication, the global
    liothyronine market is segmented into
  • Hypothyroidism
  • Goiter
  • Myxedema
  • On the basis of region, the global liothyronine
    market is segmented into
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

9
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//www.coherentmarketinsights.com/
    ongoing-insight/liothyronine-market-4159/research-
    methodology

10
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

11
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

12
  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
Write a Comment
User Comments (0)
About PowerShow.com